Drug Research
ASLAN, Thermo Fisher Join To Manufacture High Concentration Formulation...
ASLAN Pharmaceuticals , a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, and Thermo Fisher Scientific Inc, the world leader...
Drug Research
Hong Kong University Develops Bone Anabolic Therapy Aptamer
The molecular target for bone anabolic therapy has been discovered by a research team headed by Hong Kong Baptist University (HKBU), utilising a particular aptamer...
Drug Research
Nykode Therapeutics and Richter-Helm BioLogics Enter Manufacturing Partnership
Nykode Therapeutics, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, has entered into a manufacturing partnership with Richter-Helm BioLogics to...
News
NHS Cancer Treatment Rates Highest Ever Recorded In 2022
The NHS has released encouraging statistics regarding cancer rates in the UK to kick off the new year. Over the past year, more patients than...
Drug Research
Antibiotic Resistance Being Weakened By Persistent Bacteria
Researchers from Uppsala University in Sweden have released a study on how various antibiotic treatments affect different types of bacteria and how they respond to...
Clinical Trials
CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical...
CardieX Limited, a global health technology company focused on patient-centric healthcare research and improving clinical trial patient outcomes announced a partnership between its ATCOR subsidiary...
News
Japan’s MHLW approves AstraZeneca’s Imfinzi, Imjudo for liver, lung...
The Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved AstraZeneca’s immunotherapies Imfinzi (durvalumab) and Imjudo (tremelimumab) to treat advanced liver, biliary tract, and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.